病例报告:高伤心肌病与左心室超结合:从混合性心肌病到具有超结的高伤心肌病
Yang Li1, Yang Liu1, Xiaofei Zheng2
1Department of Cardiology, School of Medicine, Zhongda Hospital, Southeast University, Nanjing, China.
Frontiers in cardiovascular medicine
|December 12, 2025
概括
这份病例报告详细介绍了一名患有心力衰竭和栓塞事件的患者,诊断出患有多变性心肌病症和左心室非紧缩. 这种罕见的同时发生需要根据欧洲心脏病学会指南更新诊断.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 内部医学 内部医学
背景情况:
- 一个年轻的男性呈现出恶化的心力衰竭和反复发生的栓塞事件.
- 之前的诊断是多变性心肌病 (HCM) 和左心室缩功能障碍,治疗不规则.
- 心声图和心脏MRI显示左心室心肌不紧缩与HCM相结合.
研究的目的:
- 描述一种罕见的左心室非紧缩和高伤性心肌病并存的罕见病例的临床特征,治疗和结果.
- 根据最新的欧洲心脏病学会指南,突出显示诊断更新.
- 为了解这种结合性心脏病的理解做出贡献.
主要方法:
- 案例报告的呈现方式.
- 诊断成像包括心声回声和心脏磁共振 (MR) 检查.
- 欧洲心脏病学会对诊断和分类的指导方针的审查.
主要成果:
- 这名患者被诊断出左心室肌动脉非紧缩,除了心肌缩心脏病外.
- 这种联合诊断代表了左心室缩和超结的罕见共存.
- 诊断标准根据最近发布的欧洲心脏病学会指南进行了更新.
结论:
- 左心室非紧缩和高伤心肌病的共存是一种罕见的临床实体.
- 准确的诊断和更新的分类对于适当的患者管理至关重要.
- 这一案例强调了先进成像和在复杂的心脏病中遵守指南的重要性.
相关概念视频
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


